000 01625 a2200433 4500
005 20250516070822.0
264 0 _c20120504
008 201205s 0 0 eng d
022 _a1521-0103
024 7 _a10.1124/jpet.111.186957
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSharina, Iraida
245 0 0 _aCobinamides are novel coactivators of nitric oxide receptor that target soluble guanylyl cyclase catalytic domain.
_h[electronic resource]
260 _bThe Journal of pharmacology and experimental therapeutics
_cMar 2012
300 _a723-32 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aCatalytic Domain
650 0 4 _aCell Line, Tumor
650 0 4 _aCobamides
_xpharmacology
650 0 4 _aGuanylate Cyclase
_xdrug effects
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aNitric Oxide
_xphysiology
650 0 4 _aPyrazoles
_xpharmacology
650 0 4 _aPyridines
_xpharmacology
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aReceptors, Cytoplasmic and Nuclear
_xdrug effects
650 0 4 _aSoluble Guanylyl Cyclase
650 0 4 _aStructure-Activity Relationship
650 0 4 _aVitamin B 12
_xpharmacology
700 1 _aSobolevsky, Michael
700 1 _aDoursout, Marie-Francoise
700 1 _aGryko, Dorota
700 1 _aMartin, Emil
773 0 _tThe Journal of pharmacology and experimental therapeutics
_gvol. 340
_gno. 3
_gp. 723-32
856 4 0 _uhttps://doi.org/10.1124/jpet.111.186957
_zAvailable from publisher's website
999 _c21393218
_d21393218